Key Takeaway
A second factory for NG Biotech in Brittany
In Ille-et-Villaine, NG Biotech started production in April on its Guipry-Messac site and has just had a second factory delivered in the same town. The objective is to reach capacities of 2 million tests per month in July, and to increase from 3 to 4 million per month before the end of the year. Since the start of the year, the company has grown from just over 40 employees to almost 80 employees. And orders are pouring in. On May 18, NG Biotech unveiled an order for 100,000 units by the Paris Hospitals (AP-HP), with a similar order from the Brittany region, and another for 20,000 tests for Ille-et-Villaine. The company was also selected to integrate the Ile-de-France region's purchasing platform and its order for 5 million serological tests.
- Forums
- ASX - By Stock
- AT1
- AT1 French News Discussion
AT1 French News Discussion, page-19
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $13.42M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.0¢ | $8.115K | 394.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 650696 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 5440 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 650696 | 0.020 |
5 | 340742 | 0.019 |
5 | 450453 | 0.018 |
5 | 735888 | 0.017 |
1 | 200001 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 5440 | 1 |
0.023 | 670706 | 2 |
0.024 | 270000 | 4 |
0.025 | 332555 | 3 |
0.026 | 995368 | 3 |
Last trade - 14.22pm 15/11/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online